Advanced Search
Contact
|
Corporate
|
Help
Home
Software Solutions
Login Now
Supplier Management(SRM) >>
Overview
CMO/CRO Projects
Construction Projects
Equipment Purchases
HR Services
Sales and Marketing
Security
Login Now
Client Portal >>
Overview
Security
Login Now
Software-as-a-Service
RFP Calculator
Product Tour
FAQs
Resources
Clinical Trials
Company Directories >>
Biotech & Pharma
CMOs & CROs
Engineering & Architecture
HR & Recruiters
Law Firms
Real Estate
Events
Jobs
News >>
Current News
Feb 22, 2012
Feb 21, 2012
Feb 20, 2012
Feb 17, 2012
Feb 15, 2012
Feb 14, 2012
Feb 13, 2012
Feb 10, 2012
Feb 09, 2012
Feb 08, 2012
Feb 06, 2012
Feb 03, 2012
Industry Organizations
Regulatory Resources >>
Consultants
FDA Documents
ICH Documents
Worldwide Agencies
Useful Websites
Corporate
About Us
Careers
Corporate News
Contact
Partners
SourceSolution IQPC Workshop
Company Directories >>
CMOs/CROs
Biotech/Pharma
Professional Services
Regulatory Consultants
Events
News >>
Current News
Daily News Email Sign-up
Industry Organizations
Jobs
Regulatory Resources >>
FDA Documents
ICH Documents
Regulatory Agencies
Documents
Useful Websites
Clinical Trials
Daily news email for January 19, 2012 |
Click here for updated news
SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.
Manage projects more efficiently. Try PlanIt free for 15 days.
Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.
Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month
Use PlanIt as your next deal room! Click here to learn more.
b3c newswire
Biotage Releases New Catalog and Technical Guide for Sample Preparation and Evaporation
Sartorius Stedim Biotech and G-Con Manufacturing Announce Global Collaboration
JSR Expands its Biomedical Business by Investing in BIA Separations' Unique Purification Technology
BrainStorm Announces Clinical Data for Safety and Supporting Efficacy of NurOwn(TM) Based on ...
AMSilk is Proud to Announce the Addition of Jeff Davis to its Advisory Board
BioSpace
4SC AG Says Its Resminostat Meets Primary Endpoint In Phase II Trial; Stock Rises +0.57(38.51%) @ 11:36AM EST
Sandoz, Inc. Initiates Two More Phase III Amgen Biosimilar Trials
EU OKs Mass. Plant for Genzyme Corporation's Fabry Disease Drug, FDA Still Needs to Get on Board
"Upper Normal" Blood Pressure Linked to Heart Risk in Men, University of Oslo Study
Depression Drugs "Causing Falls," Erasmus University Medical Center Study
BioSpace - Breaking News
ShangPharma Achieves First Milestone in Jiangsu Hengrui Medicine Co. Ltd. Biologics Partnership
Watson Pharmaceuticals, Inc. Launches Generic Yaz(R)
Commonwealth Laboratories, Inc. and Health Point Press Announce a New Association Which Will Work to Promote Small Intestinal Bacteria Overgrowth (SIBO) and its Correlation to Irritable Bowel Syndrome (IBS)
A*STAR, GE Global Research Join Forces to Develop Integrated Advanced Medical Imaging Technologies for Improved Clinical Diagnosis
HUYA Bioscience International Announces Strategic Partnership with the
Biotech News - Business Wire
Commonwealth Laboratories, Inc. and Health Point Press Announce a New Association Which Will Work to Promote Small Intestinal Bacteria Overgrowth (SIBO) and Its Correlation to Irritable Bowel Syndrome (IBS)
Mirus BiosciencesFugent
Cannabis Science Updates Second Medical Cannabis Cancer Patient Suffering from Squamous Cell Carcinoma Photo-documents Cannabis Extracts Killing Cancerous Tumor
NanoIsrael 2012: Top Global Researchers, Achievements in Science and Business, and Potential Investors
Verisk Health's HEDIS Solution Fully Certified and Ready for the 2012 Season
Biotech News - PR Newswire
Ambry Genetics Reports Results from Clinical Diagnostic Exome Testing of Three Patients
EveryDayMatters.com Aims to Raise Awareness and Coordinate Care Between Mental and Physical Health
China Health Resource Pharmaceutical Grade Gastrodia Product Line Expected to Contribute $8 Million in Revenue to 2011 Year End
GeNO LLC Makes Significant Additions to Management Team to Increase Capability and Talent
Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock
Biotechnology - Moreover
Research highlights key role grandmothers play in mother and child nutrition and health
IBB: ETF Outflow Alert
CNA extends offering for pharmaceutical and biotech companies
Origin Agritech swings to yearly loss; shares fall
Immunogen, inc. announces conference call to discuss its second quarter fiscal year 2012 financial results
Burrill Report
Novartis to Ax 2,000 jobs after Tekturna Development Halted
Genentech Partners with Xenon Pharmaceuticals in $646M Pain Pact
Forma Therapeutics Inks Alliance with Janssen Biotech
Bristol-Myers Squibb Buys Inhibitex for $2.5 Billion
Flagship Ventures Launches $270 Million Fund
CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Au vu des résultats positifs d'une analyse intermédiaire le Comité indépendant de surveillance et de sécurité de l'étude clinique FAME II de St. Jude Medical recommande l'arrêt des inclusions
Samenvatting: De FAME II onafhankelijke Data Safety Monitoring Board (DSMB) beveelt St. Jude Medical een patiënten opnamestop aan voor de FAME II clinische trial na een positieve tussen analyse.
Resumen: Sapheon anuncia los resultados en humanos después de un año; comienza la inscripción para estudio europeo de postventa
Research and Markets: Inflammation Global Clinical Trials Review, H2, 2011
Sapheon gibt einjährige Ergebnisse von erstmals am Menschen durchgeführter Studie bekannt; Rekrutierung für europäische Post-Market-Studie beginnt
Clinical Trials - PR Newswire
Combination of Oral Drugs Suppresses Common Type of Hepatitis C, According to University of Michigan-led Research
BioElectronics' Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery
IRBNet Announces Release of National Research Network® 2011 Benchmark Report
DATATRAK Releases New Version of uIRT
Scripps-led Study in JAMA Shows New Drug Helps "Bridge" Stent Patients to Cardiac Surgery
CNN Top Stories
Apple: School should center on iPad
Roads icy after Pacific Northwest storm
Rescue efforts on Concordia may end
Hollywood park searched for body parts
Lawmaker, others get hacking payouts
Contract Pharma
Suzhou Pharma Services Appoints President
SGS To Open Second Facility in Mumbai
Patheon Adds Soft Gel Capabilities Via Procaps Pact
Astellas Appoints UK Ops Head
Pii Expands Aseptic Facilities
FDA Drugs- What's New
Medication Guides
FDA Drug Safety Communication: New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin)
FDA Drug Safety Communication: Update: Preliminary findings from ongoing investigations of CardioGen-82
FDA Statement on recently terminated clinical trial with Doribax (doripenem)
Questions and Answers: FDA approves a class Risk Evaluation and Mitigation Strategy (REMS) for transmucosal immediate-release fentanyl (TIRF) medicines
FDA News - Business Wire
CardioComm Solutions, Inc. Receives FDA Clearance to Market First Over-the-Counter Heart Monitoring Solution
La Agencia de Alimentos y Fármacos de EE.UU. aprueba nuevas formulaciones de Viread® para su uso en niños con VIH
Gore Receives First FDA Approval for Endovascular Repair of Traumatic Aortic Transections
Cancer Patients Experience Increased Survival Time After Pathwork Tissue of Origin Test
Bristol-Myers Squibb and AstraZeneca Receive Complete Response Letter from U.S. Food and Drug Administration for Dapagliflozin
FDA Press Releases
FDA approves Voraxaze to treat patients with toxic methotrexate levels
FDA to protect important class of antimicrobial drugs for treating human illness
FDA: Chicago-area sandwich manufacturer agrees to stop production
FDA expands use of HIV drug Isentress to children and adolescents
FDA: Do not use ShoulderFlex Massager
FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking Information for Consumers
Cord Blood Banking – Information for Consumers
Cord Blood Banking ââ¬â Information for Consumers
Influenza Virus Vaccine for the 2011 - 2012 Season
Fluzone, Fluzone High-Dose and Fluzone Intradermal
FierceBiotech
4SC surges on positive midstage data for advanced liver cancer
Animal rights activists boiling mad at BMS
Quintiles to hire 500 for new BPO hub in China
Frazier preps venture fund to back biotechs built for sale
Bristol-Myers reports interferon-free cures in small PhII hep C study
FierceBiotech IT
Medidata chief calls company 'the cloud' for clinical data
AB Sciex, Indigo BioSystems join forces on mass spectrometry software
DecisionView updates clinical trial enrollment software
Entelos stages comeback bid with funding
PerkinElmer CEO arranges marriage between informatics, lab service biz
FierceBiotech Research
Altering intestinal bacteria with probiotics improved rats' heart health
Sugar molecules betray precancerous cells in esophagus
PARP inhibitors could aid larger ovarian cancer patient population
Vitamin D helps (more than) 3 (nearly) blind mice see
Hormone irisin eyed as possible weight loss drug ingredient
FiercePharma
Pharma gets its close-up in new Hollywood films
UPDATED: J&J said to settle TX Risperdal case for $158M
AZ chief: Emerging markets are tougher than you think
Adding MEK drug to Zelboraf could stymie secondary cancers
No more working Saturdays at exports-minded Cipla
FiercePharma Manufacturing
Toray takes stake in Mitsui bio-CMO
Genzyme revives Fabrazyme with EMA plant OK
Lean earns Lundbeck big prize, cost cuts
Bioprocess budget hikes a sign of efficiency quest
Novartis, Lundbeck score wins for manufacturing in the West
FierceVaccines
Confident Inovio chief pushes ahead on universal flu vaccine
Paragon nabs $15M filovirus vax contract from DoD
Scientists balk as U.S. gov't pushes limits to bird flu discourse
Breast cancer vaccine set for large-scale testing
Flu season gets off to a sluggish start
Health News - BizJournals.com
Meet today's 40 Under 40: James David Lehmann Jr.
$2M ER investment complete at Buffalo General
Supreme Court's Antonin Scalia sounds off at law gathering
Enrollment opens for cancer prevention study
Anthem, Norton agree to three-year extension
Health News - CNBC
WebMD says expected possible bids would be too low
Analysis: Goal for Alzheimer's drug by 2025 too ambitious
Cash-strapped Ireland tests limits of austerity
Neurocrine Biosciences plans $77M stock offering
FDA won't approve Bristol-Astra diabetes drug yet
Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared
Employers Grateful for Proposed Tax Breaks, Still Scared
Insmed Shares Drop as FDA Halts Study After Rat Test Results
Week Ahead: A Flood Of 2Q Earnings
Pfizer Drug Raises Heart Attack Risk: Study
Inside Industry - Gen
GEN Poll Voters Divided on Prospects for Growth of Emerging Bioclusters
Quintiles Takes Majority Stake in Oxford Cancer Biomarkers
Bayer Plans 2012 Filing for Regorafenib Following Positive Phase III mCRC Trial Results
FDA Clears BTG's Voraxaze for Treating Methotrexate Toxicity
Pherecydes Receives Grant to Develop Bacteriophage Therapies for Skin Infections
Marketwire - Pharma and Biotech
Aptalis Pharma annonce que la FDA a approuve NDA pour une poudre ngestion par voie orale de Viread(R), co-dloppavec Gilead Sciences, Inc.
Health Care Without Harm Calls Kaiser Permanente's Purchasing Change "A Huge Step Toward Making Health Care Healthier"
Science Magazine Showcases Groundbreaking Bio Architecture Lab Technology That Efficiently Converts Seaweed to Renewable Fuels and Chemicals
Winchester Systems Releases New White Paper for Mobile Military Surveillance Data Recorders
Growth of Vaccines Calls for Better, Faster Production
MassBio News
451 Marketing & Freeman to Create Massachusetts Pavilion at 2012 BIO International Convention
Local students explore Biotech Futures
A Note from the President: Looking Forward to a Busy 2012 at MassBio
BIO International Convention Returning to Boston in 2012
The Blogs MassBio Reads
Medical Pharma - PR Newswire
UBM Medica's Psychiatric Times Offers Help for Clinicians Treating Personality Disorders
Fish & Richardson Attorneys Tom Melsheimer, Tommy Jacks Help Whistleblower, State of Texas Earn Historic Settlement in Lawsuit Over Risperdal Medication
March of Dimes to Launch Prematurity Prevention Network
Salk Scientist Ronald M. Evans Wins 2012 Wolf Prize in Medicine
The Raleigh Eye Center Selects TSI Healthcare and NextGen
National Center for Biotechnology Information
GEO Series Releases
ClinVar News and Announcements
Behind The Headlines - Health News from NHS Choices
PubMed Health Featured Reviews
SRA News
Nature Biotechnology
Approval on a knife edge
Bringing business risk into sharp focus
The NIH's role in accelerating translational sciences
Building stem-cell genomics in California and beyond
Foundation Medicine
New York Times- Biotechnology
Amgen and Watson to Work Together on Generic Drugs
A Genome Deluge
Drew Endy: Better Computing for the Things We Care About Most
DNA Sequencing Caught in Deluge of Data
China’s New Economic Plan Focuses on Raising Standards of Living
New York Times- Pharmaceuticals
Pill Organizers Pretty Enough to Come Out of the Cabinet
U.S. to Tell Drug Makers to Disclose Payments to Doctors
DEALBOOK; Bristol-Myers Agrees to Buy Inhibitex for $2.5 Billion Cash
CVS Caremark Settles Charges Over Prescription Prices
CVS Settles Charges Over Prescription Prices
OnBioVC
Monteris Medical, Inc.: Series C $8.6M
Sorbent Therapeutics, Inc.: Series B
OnBioVC: End Piracy, Not Liberty
Verastem, Inc.: Series B $32M
Transcend Medical, Inc.: Series B $16M
Outsourcing-Pharma
Parexel discusses transdermal drug delivery techs
Sponsors and CROs differ on perception of service quality, says the Avoca Group
Recipharm CEO talks CMO sector recovery and Asian plans
Covance adding mass spec for biosimilars
Embedded service providers are future of the industry, says RPS
Pharma News - Business Wire
Research and Markets: Schizophrenia Product Profiles: Adjunctive treatments to carve new niche in mature market
Research and Markets: Alzheimer's Disease Product Profiles: immunotherapies can revolutionize treatment paradigm
Research and Markets: Injectable Drug Delivery: Drugs, Devices, Targets, Therapeutics and Forecasts
Research and Markets: Pen Injectors: Devices, Drugs, Combination Products
Advanced BioNutrition Signs Third Agreement with Centovet Laboratories, its Strategic Chilean Partner
Pharma News - PharmiWeb
Dr. Gregory S. Hageman Awarded Prestigious Pisart Vision Award by Lighthouse International
W. L. Gore & Associates Named a Top U.S. Workplace
Michael Strahan and Hungry Girl Lisa Lillien Team Up For St. Jude Game Day. Give Back. to Support St. Jude Children's Research Hospital®
Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight
Martindale Pharma® launches Latanoprost eye drop solution
Pharma News - PR Newswire
Berkery Noyes Releases 2011 Pharma & Healthcare Information and Technology Industry Mergers & Acquisitions Report
Pharmacists Ask Medicare to Help Seniors Complaining About Inadequate Pharmacy Access in Medicare Prescription Drug Plans
National Online Directory of Permanent Prescription Drug Collection Boxes Launched
PediatRx reports revenues and third quarter results
Catalina Council Boy Scouts Partner With Sanofi US Tucson Research Center to Host First-Ever Chemistry Merit Badge Program
Pharmaceutical - Moreover
Billion Dollar Quarterly Research & Development Club: Who Turns R&D Into Stockholder Gains
Business Development Director: A Global CRO
Fengyuan Pharmaceutical Forecasts 2011 Earnings To Fall 74.7...
Regulatory Business Development Director
Senior Clinical Research Physician - Sweden
PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products
AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store
Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle
AL-TAR Services, Inc. Names Robert Nugent Director of Business Development
Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute
PRWeb - Biotechnology
November Research Group Appoints Senior Bio-Pharmaceutical Industry...
Antibiotic Development Pipeline and Strategies Analysed in New...
Microfluidics and Quadro Engineering to Present Webinar on Vaccine and...
Healthcare Data Solutions Announces New Vice President of Technology...
Safe-Guard PET-G Optics Packaging Launches Online Size-Finder
PRWeb - Pharmaceuticals
CSA Awarded Covert Supply Chain Tracking and Tracing Contract
Craig Hospital Improves Clinical Forms Processes and Patient Safety...
Apex Plastics expands Plastic Flat Oval Container Line
Ernest Mario Joins the Board of Delpor, Inc.
US Drug Watchdog Calls Its Osteoporosis Drug Fosamax Initiative &...
Scientific American
Dirty Dancing: Dung Beetles Get Down to Walk the Line
Rainforest in Transition: Is the Amazon Transforming before Our Eyes
Trumpeter Swans Rebound, with an Assist from Global Warming
SOPA Opera: White House Shuts Down Online Anti-Piracy Bill
SOPA Opera: White House Shuts Down Proposed Online Anti-Piracy Bill
Sports - ESPN Basketball
Thames' 22 fuel S. Diego St. to 9th straight win
Buckner, Ole Miss upend rival Mississippi State
Creighton staves off Missouri State's upset bid
Nebraska erases 13-point deficit, stuns Indiana
Murray State nips Morehead St., reaches 19-0
Sports News - ESPN
Ex-QB Schlichter had two positive cocaine tests
Tulsa names Parmley as new athletic director
Record 65 players declare early for NFL draft
Warrant: Schlichter violated bond conditions
Report: Trustees say Paterno didn't do enough
Xconomy Life Sciences
Xconomist of the Week Chris Rizik: Who Says VC Has No Soul
Xconomist of the Week Chris Rizik: Who Says VC Has No Soul
Reinventing Biotech's Business Model: Leaders Converge in Seattle April 3
Frazier Healthcare Aims for First Biotech VC Fund After Financial Crisis
A Good News-Bad News Night for Bristol's Diabetes and Hepatitis Drugs
Yahoo Biotech News
Genes Important to Keep Brain Sharp Through Old Age (LiveScience.com)
Genes May Guide Intelligence Throughout Life (HealthDay)
Genes May Give Clues to Severe Form of Lupus (HealthDay)
BrainStorm sees positive data in ALS stem cell trial (Reuters)
Why Can't Mitt Romney Be Pro-Life About Corporations (ContributorNetwork)